We are live on
!
Find out more
TI
Telemetry Investments Portfolio holdings
AUM
$63.3M
1-Year Est. Return
0.06%
This Fund
S&P 500
This Quarter
Est. Return
+3.57%
1 Year Est. Return
+0.06%
3 Year Est. Return
+77.42%
5 Year Est. Return
+156.79%
10 Year Est. Return
–
AUM
$280M
AUM Growth
+$67.3M
(+32%)
Cap. Flow
+$33.3M
Cap. Flow
% of AUM
11.88%
Top 10 Holdings %
Top 10 Hldgs %
60.54%
Holding
172
New
57
Increased
29
Reduced
26
Closed
33
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Avista
AVA
|
+$3.15M |
| 2 |
Globalstar
GSAT
|
+$2.67M |
| 3 |
KITE
Kite Pharma, Inc.
KITE
|
+$2.38M |
| 4 |
ABCO
Advisory Board Co
ABCO
|
+$2.29M |
| 5 |
PRXL
Parexel International Corp
PRXL
|
+$2.11M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
WOOF
VCA Inc.
WOOF
|
+$2.62M |
| 2 |
MBLY
Mobileye N.V.
MBLY
|
+$2.26M |
| 3 |
CAB
Cabela's Inc
CAB
|
+$1.93M |
| 4 |
NXP Semiconductors
NXPI
|
+$1.9M |
| 5 |
PNRA
Panera Bread Co
PNRA
|
+$1.82M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 7.94% |
| 2 | Communication Services | 2.48% |
| 3 | Utilities | 1.74% |
| 4 | Technology | 1.73% |
| 5 | Financials | 1.63% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
SCLN
101
DELISTED
Sciclone Pharmaceuticals Inc
SCLN
| $246K | 0.09% |
22,000
+10,000
| +83% | +$110K |
|
102
SPDR Gold Trust
GLD
$131B
| $243K | 0.09% |
+2,000
| New | +$243K |
|
103
SBA Communications
SBAC
$18.6B
| $241K | 0.09% |
+1,675
| New | +$238K |
|
|
AET
104
DELISTED
Aetna Inc
AET
| $241K | 0.09% |
+1,515
| New | +$237K |
|
105
Charter Communications
CHTR
$16.7B
| $238K | 0.09% |
+655
| New | +$244K |
|
|
NIHD
106
DELISTED
NII Holdings, Inc. Common Stock
NIHD
| $237K | 0.08% |
515,000
+79,000
| +18% | +$46.5K |
|
107
CALL
Novavax
NVAX
$1.21B
| $228K | 0.08% |
+10,000
| New | +$224K |
|
108
American Tower
AMT
$79.9B
| $227K | 0.08% |
+1,660
| New | +$231K |
|
109
Anterix
ATEX
$1.78B
| $226K | 0.08% |
7,589
-8,411
| -53% | -$230K |
|
110
Cigna
CI
$79.6B
| $224K | 0.08% |
1,200
-1,475
| -55% | -$263K |
|
|
SFR
111
DELISTED
Starwood Waypoint Homes
SFR
| $218K | 0.08% |
+6,000
| New | +$214K |
|
112
Waters Corp
WAT
$37.7B
| $206K | 0.07% |
+1,145
| New | +$208K |
|
113
Fortive
FTV
$19.5B
| $205K | 0.07% |
+4,599
| New | +$191K |
|
|
STML
114
DELISTED
Stemline Therapeutics, Inc.
STML
| $205K | 0.07% |
18,500
-6,500
| -26% | -$61.1K |
|
|
UNIT
115
Uniti Group
UNIT
$2.53B
| $180K | 0.06% |
+12,275
| New | +$259K |
|
|
ADAP
116
DELISTED
Adaptimmune Therapeutics
ADAP
| $170K | 0.06% |
+20,710
| New | +$129K |
|
|
GG
117
DELISTED
Goldcorp Inc
GG
| $157K | 0.06% |
+12,150
| New | +$160K |
|
118
CALL
Barclays
BCS
$91B
| $155K | 0.06% |
15,690
-78
| -0.5% | -$773 |
|
|
119
Barclays
BCS
$91B
| $155K | 0.06% |
+15,690
| New | +$156K |
|
|
120
PUT
Barclays
BCS
$91B
| $155K | 0.06% |
15,690
-78
| -0.5% | -$773 |
|
|
CPN
121
DELISTED
Calpine Corporation
CPN
| $148K | 0.05% |
+10,000
| New | +$143K |
|
122
Element Solutions
ESI
$8.89B
| $139K | 0.05% |
+12,466
| New | +$154K |
|
|
SIOX
123
DELISTED
Sio Gene Therapies Inc. Common Stock
SIOX
| $138K | 0.05% |
+2,500
| New | +$422K |
|
|
SPWR
124
DELISTED
SunPower Corporation Common Stock
SPWR
| $109K | 0.04% |
+22,752
| New | +$138K |
|
|
OSG
125
DELISTED
Overseas Shipholding Group Inc.
OSG
| $60K | 0.02% |
22,700
| – | – |
|
Similar funds
SF
CAM
SCFS
LCH
SGMPI
HJMC
AI
DFAM
Telemetry Investments's Q3 2017 Portfolio in Review
As of Q3 2017, Telemetry Investments held 172 positions worth $280M, up 32% from $213M the previous quarter. Its ten largest holdings account for 61% of the portfolio.
Telemetry Investments deployed $33.3M of net new capital in Q3 2017, opening 57 new positions and adding to 29 existing holdings. Its largest new stake was Avista: 62,927 shares worth $3.26M.
By sector, the portfolio is most concentrated in Healthcare at 7.9% of assets, down from 9.6% a quarter earlier, followed by Communication Services and Utilities.
On the sell side, the largest reduction was NXP Semiconductors, an estimated $1.9M trimmed.
- Telemetry Investments's largest Q3 2017 buy was Avista: 62,927 shares worth $3.26M.
- Telemetry Investments added most to Parexel International Corp in Q3 2017, an estimated $2.11M increase.
- Telemetry Investments's biggest Q3 2017 reduction was NXP Semiconductors, cutting an estimated $1.9M.
- Telemetry Investments fully exited VCA Inc. in Q3 2017, selling an estimated $2.62M.
- Telemetry Investments's ten largest holdings make up 61% of its $280M portfolio in Q3 2017.
- Telemetry Investments opened 57 new positions and closed 33 in Q3 2017.
- Telemetry Investments's portfolio value rose 32% quarter-over-quarter to $280M.
Based on Telemetry Investments's 13F filing for Q3 2017, filed 14 Nov 2017.